V(D)J recombination is essential for the maturation of lymphocytes. Because of the involvement of cutting and joining DNA double strands, this recombination activity is strictly contained within the noncycling phases of the cell cycle. Such containment is crucial for the maintenance of genomic integrity. The ataxia telangiectasia mutated (ATM) gene is known to have a central role in sensing general DNA damage and mediating cell-cycle checkpoint. In this study, we investigated the role of ATM and its downstream targets in the cell-cycle control of V(D)J recombination in vivo. Our results revealed the persistence of double-strand breaks (DSBs) throughout the cell cycle in ATM À/À and p53 À/À thymocytes, but the cell-cycle regulation of a V(D)J recombinase, Rag-2, was normal. The histone variant H2AX, which is phosphorylated during normal V(D)J recombination, was dispensable for containing DSBs. H2AX was still phosphorylated at V(D)J loci in the absence of ATM. Therefore, V(D)J recombination, a physiological DNA rearrangement process, activates the ATM/p53 pathway to contain DNA breaks within the noncycling cells and surprisingly this pathway is not important for containing Rag-2 activity. This study shows the dynamic multiple functions of ATM in maintaining genomic stability and preventing tumorigenesis in developing lymphocytes.
Introduction
The majority of leukemias and lymphomas carry chromosomal translocations involving the antigen receptor and certain oncogene loci (Tsai et al., 2008) . These types of chromosomal translocations usually lead to deregulation of oncogenes that results in tumorigenic transformation . In developing lymphocytes, initiation of these chromosomal translocations occurs when DNA double-strand breaks (DSBs) are generated during the normal development to assemble diversified antigen receptor genes. DSBs are the most dangerous form of DNA damage, particularly to actively proliferating cells. Therefore, rigorous cellcycle surveillance must be enforced to maintain genomic integrity and coordinate DNA damage repair with proliferation in developing lymphocytes.
V(D)J recombination is a genetically programmed DNA rearrangement process occurring during the early development of lymphocytes that results in assembly of highly diversified antigen receptors essential to functional lymphocytes. V(D)J recombination consists of cleaving germ-line DNA by the lymphoid-specific nucleases, Rag-1 and Rag-2 (RAG), at recombination signal sequences (Schatz et al., 1989; Oettinger et al., 1990) , creating two types of DSBs: blunt, 5 0 -phosphorylated signal ends and covalently sealed coding ends. Both are considered intermediates of V(D)J recombination (McBlane et al., 1995; Zhu and Roth, 1995) . Following DNA cleavage, the signal ends are joined by a single ligation step whereas the coding ends are processed before joining. Both end-joining events are mediated by the nonhomologous end joining pathway. Owing to the danger of generating DSBs within cells that possess high proliferative potential, stringent regulation of recombination is crucial for developing lymphocytes to maintain genomic integrity. Regulation is accomplished by limiting the recombination activity to the noncycling (G 0 /G 1 ) stages of the cell cycle (Desiderio et al., 1996) . Rag-2, one of the nucleases essential to V(D)J-mediated DNA cleavage, is rapidly phosphorylated and degraded before transition of the cell from G 1 to S phase (Jiang et al., 2005) . Repair of RAG-generated DSBs is fully completed before the cell enters S phase. Because Rag-2 activity is absent in the S phase, DNA cannot be newly cleaved and the V(D)J intermediates are completely absent in the cycling (S/G 2 /M) phases (Schlissel et al., 1993) .
In response to general DNA damage, the protein kinase ataxia telangiectasia mutated (ATM) is activated by autophosphorylation (Bakkenist and Kastan, 2003; Lee and Paull, 2005) , then phosphorylates many downstream targets including the histone variant H2AX (Rogakou et al., 1998) . Ultimately, this signaling cascade activates p53, leading to cell-cycle checkpoint activation (Lavin, 2008) , repairs DNA damage and/or induces apoptosis. Because V(D)J recombination is a physiological event, the resulting DSBs are not expected to induce a massive damage response under normal circumstances. Indeed, no evidence of p53 activation is observed in normal thymocytes, although signal ends are readily detectable (Guidos et al., 1996) . Interestingly, ATM and phosphorylated p53 were found at a V(D)J recombination locus undergoing active rearrangement (Perkins et al., 2002) . This finding suggests the presence of a cell-cycle surveillance mechanism during recombination, which consists of monitoring DSBs and incorporating cell-cycle dependency. However, the role of p53 in the cell-cycle control during normal V(D)J recombination has not been fully elucidated.
The role of ATM in V(D)J recombination is becoming more evident. ATM-deficient mice develop thymic lymphomas characterized by chromosomal translocations near T-cell receptor (TCR) loci (Liyanage et al., 2000; Winrow et al., 2005) . ATM may also function directly in end joining, end processing or end protection (Bredemeyer et al., 2006 (Bredemeyer et al., , 2008 . In addition, a recent study reported the persistence of chromosomal breaks in actively dividing ATM-deficient peripheral lymphocytes (Callen et al., 2007) , suggesting a role for ATM in cellcycle control in addition to facilitating DNA repair. However, the mechanism behind the involvement of ATM in the cell-cycle checkpoint during V(D)J recombination, along with the functions of ATM downstream targets responsible for cell-cycle control, has yet to be determined. In this study, we sought to investigate the role of ATM in the regulation of the cell cycle during V(D)J recombination by three different approaches. We directly examined the V(D)J intermediates in the context of cell cycle in the ATM-deficient background; we determined the potential function of ATM in the cellcycle control of RAG nucleases and finally, we examined the contributions of known ATM downstream targets, p53 and H2AX, in the control of recombination-mediated DSBs. Our study indicates multiple roles of ATM in cell-cycle surveillance in addition to end joining. It is therefore a key molecule in the maintenance of genomic stability in developing lymphocytes.
Results
ATM deficiency leads to persistence of signal ends throughout the cell cycle in developing lymphocytes To determine the role of ATM in cell-cycle control of V(D)J recombination in vivo, we examined the level of signal ends in an ATM deficiency. Single-cell suspensions of thymocytes were isolated, and sorted based on DNA content, from 4-week-old wild-type (WT) and ATM-deficient mice (Borghesani et al., 2000;  Figure 1a ; Supplementary Figure S1 ). Genomic DNA was isolated from thymocytes from G 0 /G 1 and S/G 2 /M phases of the cell cycle. Briefly, a pair of annealed oligonucleotides ('linker') was ligated to the DNA samples and the targets were amplified by PCR using primers specific for three different TCR loci (Supplementary Figure S2A) . Signal ends were detected at TCR Dd2 in the G 0 /G 1 fraction (Figure 1b , top panel), but not in S/G 2 /M fraction ( Figure 1b , lanes 3 and 4) of WT thymocytes. In contrast, signal ends were detected in both G 0 /G 1 and S/ G 2 /M phases of ATM-deficient thymocytes (Figure 1b , lanes 9 and 10). To further examine the putative role of ATM in cell-cycle control during V(D)J recombination, and to verify that ATM function is not locus specific, we examined for signal ends at the TCRb and TCRa loci. As expected, signal ends were only detected in the G 0 /G 1 phase of WT thymocytes (Figure 1b ; middle and bottom panels), but persisted in both G 0 /G 1 and S/G 2 /M phases of ATM-deficient thymocytes. To further reveal that these signal ends do not just survive through the G 1 /S transition, we sorted the G 2 /M phase of ATM-deficient thymocytes according to the cyclin B1 expression (Widrow et al., 1997) . Our results indicated that signal ends are also persistent in the G 2 /M phase of ATM À/À thymocytes (Supplementary Figure S3) . These results indicate that ATM has a general role in all three loci and is essential for the cell-cycle containment of DSBs during recombination.
Cell-cycle control of DSBs during V(D)J recombination is also dependent on p53 Studies based on chromatin immunoprecipitation revealed the colocalization of phosphorylated p53 and ATM at the active V(D)J recombination site (Perkins et al., 2002) , suggesting p53 might be important during normal recombination. To determine whether ATM/p53 pathway contributes to the cell-cycle restraint of V(D)J recombination-mediated DSBs, we analysed the pattern of signal end expression by ligation-mediated PCR (LMPCR) in p53-deficient mice (Donehower et al., 1992) . Genomic DNA samples from the G 0 /G 1 and S/ G 2 /M fractions revealed an obvious contrast of signal end patterns between the sorted WT and p53-deficient thymocytes. Although signal ends were not found in the S/G 2 /M phase of the WT thymocytes, signal ends were readily detected in both the G 0 /G 1 and S/G 2 /M phases of p53-deficient thymocytes (Figure 1b, lanes 6 and 7) . Similar results were observed when all three TCR loci were examined (Figure 1b ). To further confirm these results, we repeated experiments several times. Results from one of these experiments are shown in Supplementary Figure S4 . In addition, signal ends were also detected in G 2 /M phase of p53-deficient thymocytes, similar to ATM-deficient mice (Supplementary Figure  S3) . These results suggest that p53 might have a more relevant role in the cell-cycle control of DSBs during V(D)J recombination, perhaps serving as a downstream target of activated ATM and participating in the activation of cell-cycle checkpoints.
Normal signal end joining occurs in both ATM-and p53-deficient mice Persistence of signal ends throughout the cell cycle may be due to defects in repairing these ends. To determine whether the absence of ATM or p53 leads to a deficiency in signal end joining, we analysed the levels of signal end joining for the presence of circularized signal joints. DNA samples from sorted WT, ATM-and p53-deficient thymocytes were analysed by PCR for signal end joining between Dd2 and Jd1, the site we previously examined . Signal joints were detected in both the G 0 /G 1 and S/G 2 /M fractions of WT, ATM-and p53-deficient thymocytes ( Figure 1c ; Supplementary Figure S2B ). These results suggest that the overall joining of signal ends does not require the presence of ATM or p53.
Cell-cycle containment of coding ends at the TCRa locus requires ATM and p53 Although the signal ends detected at all three sites are DNA broken ends excised from chromatin, coding ends are broken DNA intermediates retained within the chromatin. Previous reports have shown low levels of coding ends detected at the TCR Ja site of ATMdeficient thymocytes (Huang et al., 2007; Vacchio et al., 2007) . We asked whether ATM and p53 are required to contain these coding ends within the cell cycle. To attain a quantitative measure, we used real-time PCR (Q-PCR) to detect coding ends, which included a pretreatment of thymocyte DNA with T4 polymerase followed by its ligation to the linker. Interestingly, our Q-PCR results showed a similar pattern as signal ends: coding ends were detected in G 0 /G 1 phase, but absent in the S/G 2 /M of WT thymocytes, whereas coding ends were persistent throughout the cell cycle in ATM-and p53-deficient mice ( Figure 1d ). This finding confirmed our LMPCR results, and corroborated the role of ATM and p53 in containing DSBs within the G 0 /G 1 phase of the cell cycle.
Cell-cycle regulation of DSBs during V(D)J recombination is independent of H2AX
In response to DNA damage, activated ATM phosphorylates many downstream targets including H2AX. In general, foci formation of phosphorylated H2AX (gH2AX) is correlated with the presence of DSBs caused wt p53 by exogenous factors or RAG-mediated cleavage (Chen et al., 2000) . To determine the potential role of H2AX in the cell-cycle containment of DSBs during V(D)J recombination, we examined the pattern of signal and coding ends in H2AX-deficient mice (Bassing et al., 2002) . Signal ends were only detected within the G 0 /G 1 phases of the cell cycle at all three TCR loci in H2AX-deficient thymocytes (Figure 1b , lanes 12 and 13; also a repeating experiment shown in Supplementary Figure  S4 ). This result was indistinguishable from WT thymocytes. Real-time PCR results also revealed similar patterns of coding ends in H2AX deficiency as in the WT mice, which were restricted within the G 0 /G 1 phases of the cell cycle (Figure 1d ). These data indicate that H2AX is dispensable for the cell-cycle containment of DSBs during recombination.
Rag-2 is cell-cycle regulated in the absence of ATM To contain DSBs in noncycling lymphocytes, it is extremely important to eliminate RAG nuclease activity before the G 1 /S phase transition. To investigate the potential role of ATM in the cell-cycle regulation of Rag-2, we determined the levels of Rag-2 in ATMdeficient and WT thymocytes throughout the cell cycle. We used a mouse model that carries green fluorescent protein (GFP) fused to the Rag-2 gene, allowing the detection of Rag-2 protein through GFP using flow cytometry (Monroe et al., 1999) . Thymocytes isolated from WT and GFP:Rag-2 mice were stained for CD4 and CD8 surface markers, DNA content and the GFP signal was amplified using an enhancement system (anti-GFP fluorescent antibody) ( Figure 2a ). As expected, GFP:Rag-2-positive cells were only detected in CD4 and CD8 double-negative (DN) and double-positive (DP) populations (Supplementary Figure S5) , which were actively undergoing V(D)J recombination. GFP:Rag-2 was not detected in matured CD4 or CD8 single-positive (SP) thymocytes or splenocytes (Supplementary Figure  S5-S7) . Furthermore, when DP and DN thymocytes were analysed separately in G 0 /G 1 and S/G 2 /M phase, Rag-2 expression was only found in the G 0 /G 1 fraction of WT thymocytes.
The GFP:Rag-2 mice were bred to the ATM-deficient background. The GFP:Rag-2/ATM-deficient mice were phenotypically undistinguishable from ATM-deficient mice. Four-week-old GFP:Rag-2 and GFP:Rag-2/ ATM-deficient mice were analysed for Rag-2 expression. GFP:Rag-2 was detected in the G 0 /G 1 fraction of total, DN and DP populations but not in the S/G 2 /M fraction of GFP:Rag-2/ATM-deficient thymocytes. These results were identical to those found in GFP:Rag-2/WT thymocytes, suggesting Rag-2 is contained within the G 0 /G 1 phases despite the absence of ATM (Figure 2b) . Similar results were observed in developing B cells from the bone marrow (Supplementary Figure  S8) . In addition, GFP:Rag-2 was not detected in SP thymocytes or splenic T cells (Supplementary Figures S6  and S7 ), indicating that in the absence of ATM, Rag-2 is developmentally regulated and contained within the cell cycle. To further explore whether age could have an effect on Rag-2 regulation, we examined mice at 2 and 6 months of age. Again, no differences were detected (Supplementary Figures S9 and S10) . These results indicate DSBs at V(D)J recombination sites are generated normally in an ATM-deficient background, but the ends are not properly regulated during the cell cycle. Therefore, ATM is essential for the cell-cycle containment of DSBs during V(D)J recombination.
Rag-2 remains cell-cycle regulated in p53-deficient mice On the basis of our LMPCR and real-time PCR results, which indicate that p53 is also required for containing DSBs within the cell cycle during recombination, we studied the regulation of Rag-2 in the absence of p53. GFP:Rag-2 mice were bred into a p53-deficient background (Donehower et al., 1992) and GFP:Rag-2/ p53-deficient thymocytes were analysed for Rag-2 expression in the context of the cell cycle. As demonstrated in Figure 2c , GFP:Rag-2 expression was detected in G 0 /G 1 phase of DN and DP thymocytes but was absent in the thymocytes from the S/G 2 /M fraction. Therefore, as observed in the ATM deficiency, p53 is required to contain DSBs produced during the G 0 /G 1 phase of the cell cycle but is dispensable for the cell-cycle regulation of Rag-2.
H2AX is phosphorylated at the V(D)J recombination sites despite the absence of ATM RAG-mediated DSBs induce H2AX phosphorylation as observed in the formation of gH2AX foci. H2AX protein can be phosphorylated by either ATM or DNA/PK complex in response to DSBs (Stiff et al., 2004) . To determine whether ATM is responsible for phosphorylating H2AX during V(D)J recombination, we assessed the formation of gH2AX foci at Ragmediated DSBs. Thymocytes were analysed for the expression of Rag-1, Rag-2 and gH2AX to identify RAG-specific gH2AX foci using GFP:Rag-2 mice. Because of the relatively low RAG expression levels in thymocytes, we isolated Rag-2-positive cells by cell sorting, the cells were stained to identify Rag-2 (GFP antibody), Rag-1 and gH2AX. Approximately 1000 cells from WT, GFP:Rag-2 and GFP:Rag-2/ATM-deficient mice were scored for (1) Rag-2 (GFP only); (2) Rag-1/ Rag-2 and (3) Rag-1, Rag-2 and gH2AX expression. Our results revealed 27% of WT and 35% of ATM-deficient cells showed triple colocalization; however, the difference was not significant (P>0.05, two-tailed t-test). These results indicate H2AX can be phosphorylated at V(D)J recombination sites in the absence of ATM.
The identification of an active site of V(D)J recombination by gH2AX foci has been previously documented using fluorescence in situ hybridization (FISH) followed by immunofluorescence detection (Chen et al., 2000) . Owing to the relatively broad RAG staining pattern, it is possible the staining may simply coexist with gH2AX in a random manner. To confirm previous results, we identified active V(D)J sites using a FISH probe specific to the TCRa locus in combination with gH2AX foci. gH2AX foci are readily detected in WT-and ATMdeficient thymocytes (Figure 3b) . By scoring approximately 1000 cells of each genotype, B6% of thymocytes had overlapping gH2AX and TCRa FISH signals. No difference between WT-and ATM-deficient mice was observed, indicating H2AX can indeed be phosphorylated in an ATM-deficient background. H2AX phosphorylation remained relatively normal in response to V(D)J recombination, therefore gH2AX is not essential to the ATM/p53 dependent cell-cycle control of DSBs during V(D)J recombination.
Discussion
Our in vivo results showed that although V(D)J recombination is a physiological DNA recombination process, it is necessary to activate a surveillance program, centered by ATM and its downstream target p53, which is critical in regulating the cell cycle to contain breaks within G 0 /G 1 and preventing cellular proliferation with persistent DSBs. The most likely role of ATM and p53 is to ensure the initiation of DNA replication only after the completion of recombination.
ATM-deficient mice succumb to aggressive thymic lymphoma with TCR-involved chromosomal translocations, suggesting these persistent breaks can lead to oncogenic translocations. However, p53-deficient mice also succumb to thymic lymphoma but usually lack clonal chromosomal translocations (Liao et al., 1998; Bassing et al., 2003) . These results suggested that the persistence of DSBs throughout the cell cycle alone might not be sufficient to induce chromosomal translocations and oncogenic transformation. A recent study reveals that chromosomal translocations require DNA breaks on both loci, IgH on Chr 12 and c-Myc on Chr 15, in B cell lymphomas (Robbiani et al., 2008) . Thus, DSBs on the partner chromosome may be a determinant for oncogenic translocation. Interestingly, analysis of human lymphoma with translocation break points suggested the role of nucleotide CpG sites and the possible involvement of RAG nucleases in generating DSBs outside TCR/Ig regions (Tsai et al., 2008) . Thymic lymphomas are the most predominant tumors found in ATM-deficient mice (Barlow et al., 1996) and we have observed these cells expressing RAG proteins (Dujka and Zhu, unpublished data). The combination of RAG expression and an imbalance in redox activity, which leads to DNA base modifications in ATM-deficient thymocytes (Yan et al., 2006) , potentially results in DSBs in nonantigen receptor loci and chromosomal translocation. This might explain why clonal translocations are not as frequent in p53-deficient mice, because such a degree of redox imbalance has not been reported in p53-deficient mice. Another possibility is that abnormal proliferation occurs in the absence of p53 independent of recombination events.
Persistence of V(D)J DSBs in p53-deficient mice is rather surprising, as recombination does not induce gross activation of p53 (Guidos et al., 1996) . It has been suggested that RAG proteins bind and protect DNA ends and therefore 'mask' these breaks and prevent p53 activation (Lee et al., 2004) . However, our results showed the role of p53 in cell-cycle surveillance during normal recombination. These V(D)J recombinationrelated breaks are not just present during the G1/S transition, which p53 is predicted to have a dominant role, yet these ends are persistent throughout the cell cycle. Perhaps physiological V(D)J recombination does not induce massive p53 activation because (1) the amount of DSBs is low, (2) cell populations with breaks are in low number and (3) cells with breaks are in transient status; if V(D)J rearrangements fail, these cells may be eliminated through apoptosis. During lymphocyte development, several rounds of V(D)J rearrangements are required for the complete assembly of antigen receptors. Although signal ends from the initial round may not be joined immediately, these ends could activate ATM-and p53-dependent surveillance mechanism to prevent cells from entering the cell-cycle prematurely. Only successful rearrangements will lead to receptor assembly, which can sense and transduce signals from the environment. This signaling cascade results in degradation of Rag proteins and completion of signal end joining, preparing the cells to enter S phase. Therefore, we propose that signal ends might not be simply leftover by-products but rather important structures for activating cell-cycle surveillance mechanisms to prevent premature progression into S phase. The ATM/p53-dependent pathway is an essential component for the containment of DSBs during V(D)J recombination and the prevention of oncogenic transformation.
Phosphorylation of H2AX is an important component of the DNA damage response mechanism. H2AX-deficient mice exhibit genomic instability and hypersensitivity to ionizing radiation (Bassing et al., 2002 (Bassing et al., , 2003 Celeste et al., 2002) . Although H2AX phosphorylation has previously been observed at V(D)J recombination loci (Chen et al., 2000) , it is not required for completion of V(D)J recombination. Our results revealed H2AX is not required to restrain DSBs within the cell cycle during recombination as H2AX-deficient mice do not show the same DSB pattern as ATM-and p53-deficient mice. This result is interesting because chromosomal breaks were observed at a higher frequency in H2AX-deficient B cells than WT during class switch recombination (Franco et al., 2006) . Accordingly, this highlights the difference between the two recombination processes and emphasizes the role of Rag proteins in protecting ends and mediating the post-cleavage complex aiding end joining. Such protection and facilitation mechanism does not exist in class switch recombination. Our results are also consistent with a current report describing that Rag protein is not required for oncogenic transformation of H2AX/p53 double-deficient lymphocytes . Further studies regarding the function of this phosphorylation event are required.
A recent report, published while this paper was under revision, revealed that ATM has a key role in phosphorylating H2AX during V(D)J recombination (Savic et al., 2009) . The results further confirm that ATM is required for maintaining a high density and maximal distance of g-H2AX on the chromatin at the V(D)J recombination loci. Consistent with our results, DNA-PKcs is also able to phosphorylate H2AX during V(D)J recombination in the absence of ATM, albeit with lower density and shorter distance from the breaks when compared with ATM-proficient cells. The level of g-H2AX foci, however, is strong enough to be recognized by our FISH approach, which, due to its technical limitation, is not sensitive enough to reveal a quantitative measure.
Although other groups have shown the importance of ATM in end joining and end protection, our results indicate a different role of ATM in the cell-cycle regulation and maintenance of genomic stability during this recombination process in vivo. Our assay merely provided a snapshot of the lymphocyte development process in a dynamic context of the thymus; further analysis of more defined population of cells at different developmental stages will yield a complete picture of cell-cycle control during V(D)J recombination. We propose that ATM is activated by unresolved DSBs, as in the form of signal ends that are likely protected from the Rag complex, and induces cell-cycle surveillance machinery until an acceptable form of the assembled antigen receptor is expressed on the cell surface and the cell receives survival and proliferation signals. The fact that cell-cycle regulation of Rag-2 is independent of ATM suggests that this signal is also important for Rag-2 degradation. Without such a signal, ATM works with its downstream targets, including p53, to mediate apoptosis. Therefore, both ATM and p53 are essential in the cell-cycle control of DNA breaks during V(D)J recombination regardless of the status of Rag-2 regulation.
Materials and methods
Mouse colony and maintenance ATM-deficient, H2AX-deficient, GFP:Rag-2 and p53-deficient mice (Donehower et al., 1992; Monroe et al., 1999; Borghesani et al., 2000; Bassing et al., 2002) along with WT mice were maintained in a specific pathogen-free barrier facility. All experiments were approved by the IACUC, at the University of Texas MD Anderson Cancer Center.
Cell sorting
Thymocytes were isolated, suspended in 0.025% NP-40/4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid solution followed by propidium iodide (PI; Invitrogen, Carlsbad, CA, USA) staining and RNase A treatment before flow cytometric sorting (Schlissel et al., 1993) . Cells were divided into two fractions-noncycling (G 0 /G 1 ) and cycling (S/G 2 /M); genomic DNA was extracted, with unsorted cells as a control. For G 2 / M cell sorting, ATM À/À or p53 À/À (from 6-to 8-week-old mice) thymocytes were fixed with cold methanol and permeabilized with PBST (phosphate-buffered saline (PBS) and 0.2% Triton X) and stained with PI and anti-cyclin B1 (Cell Signaling, Danvers, MA, USA) antibody conjugated with Alexa Fluor 647.
Ligation-mediated PCR Genomic DNA (3 mg) from sorted cells was ligated to a linker oligonucleotide set and analysed using LMPCR for the detection of signal ends (Zhu and Roth, 1995) . For coding end analysis, DNA was blunt-ended with T4 DNA Polymerase (NEB, Ipswich, MA, USA) at 1.5 U per 1 mg for 5 min at 37 1C before linker ligation. Sequences of PCR primers and probes are listed in Supplementary Figure S11 .
Real-time PCR Coding ends and actin (endogenous control) were detected using the IQ5 Bio-Rad Cycler (Bio-Rad, Hercules, CA, USA). TaqMan probes were synthesized by Biosearch Technologies (Novato, CA, USA) based on validated LMPCR primer and probe sets (Zhu and Roth, 1995) . b-Actin primer sequences are included in the Supplementary Information. Approximately 300 ng was amplified for 45 cycles in a 96-well plate using the IQ Multiplex/Powermix (Bio-Rad). Relative levels of the targets were analysed using the ddCT method (Livak and Schmittgen, 2001 ). Sequences of PCR primers and probes are listed in Supplementary Figure S11 .
Flow cytometry
Lymphocytes from the thymus, spleen and bone marrow of WT, GFP:Rag-2/Atm-and p53-deficient mice were stained with surface markers (CD4-PE, CD8-Pacific Blue; BD Biosciences, San Jose, CA, USA), fixed with 0.25% paraformaldehyde (PFA)/PBS solution, permeabilized in 0.2% Tween 20-PBS and incubated with anti-GFP antibody conjugated to fluorescein isothiocyanate (FITC; Abcam, Cambridge, MA, USA) to enhance GFP detection followed by 7-amino-actinomycin D staining (Invitrogen) . Data were collected using DakoCyan flow cytometer and analysed by FlowJo software (Tree Star, Ashland, OR, USA).
Fluorescent in situ hybridization and immunofluorescence
For immunofluorescent detection of RAG and gH2AX, thymocytes from GFP:Rag-2 and GFP:Rag-2/ATM-deficient mice were fixed in 2% PFA, permeabilized with 0.5% Triton X-100/0.025% CHAPS at 37 1C for 10 min, and stained with anti-GFP-FITC antibody; WT mice were used as a control.
